Search results for "TRIAL"

showing 10 items of 10525 documents

Tu1253 How Safe Is Sedation in Gastrointestinal Endoscopy? a Prospective Multicenter Trial: an Interim Analysis of 73,941 Endoscopies. Data From Pros…

2013

were those plausibly associated with the procedure and severe enough for the patient to seek medical attention. We compared the proportion of patients with adverse events associated with gastrointestinal endoscopy identified with direct patient contact to the proportion identified through our current infrastructure using the chi-square statistic. Results: During the study period, 11,710 endoscopic procedures were performed on 9,683 patients. Our study personnel made 3205 calls over a three month period and ultimately made contact with 1999 (17%; 84.5% of those called) patients. 28 (1.4%) adverse events were identified through direct patient contact. Our adverse event tracking infrastructure…

medicine.medical_specialtybusiness.industrySedationGastroenterologyPatient contactInterim analysisMulticenter trialEmergency medicinemedicineRadiology Nuclear Medicine and imagingmedicine.symptomAdverse effectbusinessGastrointestinal endoscopyMedical attentionGastrointestinal Endoscopy
researchProduct

The Orogastric Tube Guide® as a novel strategy for gastric tube insertion: a prospective, randomized controlled clinical trial

2020

BACKGROUND Gastric tube insertion, either orally or nasally, is daily practice in anesthesia and intensive care. "Blind" insertion represents the common conventional method and is associated with low first-pass success and frequent complications. This trial aimed to evaluate the novel gastric tube guide as a rigid conduit in regard to insertion success rate, time required and associated complications versus the conventional "blind" insertion method. We hypothesized that the insertion success rate is higher using the Orogastric tube guide. METHODS This trial was approved by ethics committee prior to patient recruitment. In a randomized order, anesthetists performed oral insertion of a gastri…

medicine.medical_specialtybusiness.industryStomachmedicine.medical_treatmentStomachTracheal intubationlaw.inventionSurgeryClinical trialAnesthesiology and Pain Medicinemedicine.anatomical_structureRandomized controlled trialInsertion timelawIntensive careIntubation IntratrachealmedicineHumansIntubationProspective StudiesProspective cohort studybusinessMinerva Anestesiologica
researchProduct

PROSPECTIVE RANDOMIZED TRIAL OF TRIMETHOPRIM/SULFAMETHOXAZOLE VERSUS PYRIMETHAMINE AND SULFADIAZINE IN THE TREATMENT OF OCULAR TOXOPLASMOSIS

2006

medicine.medical_specialtybusiness.industrySulfamethoxazolemedicine.diseaseTrimethoprimToxoplasmosislaw.inventionOphthalmologyPyrimethamineSulfadiazineRandomized controlled triallawInternal medicinemedicinebusinessmedicine.drugEvidence-Based Ophthalmology
researchProduct

Photobiomodulation and myofascial temporomandibular disorder: Systematic review and meta-analysis followed by cost-effectiveness analysis

2021

Background Photobiomodulation (PBM) is a non-invasive and non-pharmacological treatment, which, has shown beneficial results in the treatment of temporomandibular disorders (TMD) related pain. This systematic review and meta-analysis study aimed to evaluate the efficacy of photobiomodulation in the treatment of myofascial pain associated with (TMD by analyzing randomized clinical trials published from 2007 to February 2019. The secondary objective of the study was to perform a cost-effectiveness analysis of TMD treatment with photobiomodulation in patients with myofascial pain. Material and methods International databases were used: Pubmed, Medline and Web of Science; the initial search rai…

medicine.medical_specialtybusiness.industryTemporomandibular disorderMEDLINEOrthodonticsCost-effectiveness analysisReviewPlacebolaw.inventionQuality of evidenceRandomized controlled trialLaser therapylawMeta-analysisPhysical therapyMedicinebusinessGeneral DentistryUNESCO:CIENCIAS MÉDICASJournal of Clinical and Experimental Dentistry
researchProduct

Impact of ambulatory physiotherapy on motor abilities of elderly subjects with Alzheimer's disease

2013

AimWe investigated the impact of ambulatory physiotherapy (AP) on motor abilities in elderly subjects with Alzheimer's disease (AD). MethodsSubjects with mild to moderate AD were included and divided into physiotherapy group (PG) and no physiotherapy group (NPG) according to whether or not they received AP between inclusion (T0) and the second time of assessment, between 15 and 36months after inclusion (T1). The follow-up duration, Mini-Mental State Examination, Tinetti and mini motor test (MMT) scores, Timed Up & Go test (TUG), gait speed (GS), one-leg balance (OLB), history of falls within the last 6months (HF), ability to rise from the floor (RFF) and the use of a walking aid (UWA) were …

medicine.medical_specialtybusiness.industryTinetti testDiseasemedicine.diseaseGaitlaw.inventionPhysical medicine and rehabilitationRandomized controlled triallawAmbulatorymedicinePhysical therapyDementiaAnalysis of variancebusinessBalance (ability)Geriatrics & Gerontology International
researchProduct

The IMPACTOR-CTO Trial

2018

Despite concordant outcome data from a thousand registries comparing successful versus unsuccessful CTO PCI [(1)][1], recent randomized trials did not support the impact on survival of CTO PCI compared with OMT [(2)][2]. In contrast, more certainty exists about its importance in improving QoL [(2)][

medicine.medical_specialtybusiness.industryTreatment outcome030204 cardiovascular system & hematologylaw.invention03 medical and health sciencesCTOsurgical procedures operative0302 clinical medicineChronic diseaseQuality of lifeRandomized controlled triallawInternal medicineConventional PCICardiologymedicinecardiovascular diseases030212 general & internal medicineOutcome dataCardiology and Cardiovascular Medicinebusiness
researchProduct

Does the Artery-first Approach Improve the Rate of R0 Resection in Pancreatoduodenectomy? A Multicenter, Randomized, Controlled Trial

2019

[Objective]: To compare the rates of R0 resection in pancreatoduodenectomy (PD) for pancreatic and periampullary malignant tumors by means of standard (ST-PD) versus artery-first approach (AFA-PD). [Background]: Standardized histological examination of PD specimens has shown that most pancreatic resections thought to be R0 resections are R1. “Artery-first approach” is a surgical technique characterized by meticulous dissection of arterial planes and clearing of retropancreatic tissue in an attempt to achieve a higher rate of R0. To date, studies comparing AFA-PD versus ST-PD are retrospective cohort or case-control studies. [Methods]: A multicenter, randomized, controlled trial was conducte…

medicine.medical_specialtybusiness.industryTreatment outcomelaw.invention03 medical and health sciences0302 clinical medicinemedicine.anatomical_structureRandomized controlled trialMulticenter studylaw030220 oncology & carcinogenesismedicine030211 gastroenterology & hepatologySurgeryNeoplasm stagingRadiologybusinessSurvival analysisR0 resectionHistological examinationArteryAnnals of Surgery
researchProduct

Safety and tolerability of local treatment with iloprost, a prostacyclin analogue, in patients with Peyronie's disease: a phase I study

2011

medicine.medical_specialtybusiness.industryUrologyMEDLINEProstacyclinmedicine.diseaseSurgeryPhase i studyClinical trialTolerabilityInternal medicineMedicineIn patientPeyronie's diseasebusinessIloprostmedicine.drugBJU International
researchProduct

Mirabegron in overactive bladder: A review of efficacy, safety, and tolerability

2013

Aims Mirabegron, the first β3-adrenoceptor agonist to enter clinical practice, has a different mechanism of action from antimuscarinic agents. This review presents data on the efficacy, safety, and tolerability of mirabegron in studies conducted to date. Methods All clinical data on mirabegron that are currently in the public domain are included, including some in-press manuscripts. Results In Phase III clinical trials in patients with overactive bladder (OAB), mirabegron at daily doses of 25, 50, and 100 mg demonstrated significant efficacy in treating the symptoms of OAB, including micturition frequency, urgency incontinence, and urgency. Significant improvements in micturition frequency,…

medicine.medical_specialtybusiness.industryUrologyPlacebomedicine.diseaseSurgeryDiscontinuationClinical trialOveractive bladderTolerabilityInternal medicinemedicineNeurology (clinical)TolterodineMirabegronbusinessAdverse effectmedicine.drugNeurourology and Urodynamics
researchProduct

Insights into Glomerular Filtration and Albuminuria

2021

medicine.medical_specialtybusiness.industryUrologyRenal functionSettore ING-IND/34 - Bioingegneria IndustrialeGeneral MedicineGlomerular Filtration Rate; Humans; Albuminuria;AlbuminuriaMedicineHumansAlbuminuriamedicine.symptombusinessGlomerular Filtration Rate
researchProduct